end stage renal disease 2o hypertensive nephrosclerosis

Upload: gregory-litang

Post on 08-Jul-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    1/63

    End-stage renal disease

    2o hypertensivenephrosclerosis

    Presented by: Christelle Queen S. Bacalla

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    2/63

    INTRODUCTION

    End-stage renal disease (ESRD) represents a clinical state orcondition in hich there has been an irre!ersible loss o" renal"unction in hich the body#s ability to $aintain $etabolic and%uid and electrolyte balance "ails& resulting in ure$ia ora'ote$ia (retention o" urea and other nitrogenous astes inthe blood)& and these patients usually need to accept renalreplace$ent therapy (dialysis or idney transplantation) inorder to a!oid li"e-threatening ure$ia. t is the +nal stage(stage ,) o" chronic idney disease (CD). his $eansidneys are only "unctioning at /0 to /, percent o" their

    nor$al or not "unctioning at all. idney disease is usuallyprogressi!e. t typically does not reach the end stage until /0to 10 years a"ter you are diagnosed ith chronic idneydisease& hich $ay also de!elop sloly.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    3/63

    INTRODUCTION

    2ost cases o" ESRD are caused by diabetes orhigh blood pressure. Chronic idney disease (CD)is an u$brella ter$ that describes idney da$ageor a decrease in glo$erular +ltration rate (34R) "or

    5 or $ore $onths. 6ntreated CD can result in end-stage renal disease (ESRD) and necessitate renalreplace$ent therapy (dialysis or idneytransplantation). Chronic idney disease is identi+ed

    by a blood test "or creatinine. 7igher le!els o"creatinine indicate a "alling glo$erular +ltration rateand as a result a decreased capability o"the idneys to e8crete aste products.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    4/63

    INTRODUCTION

    Creatinine le!els $ay be nor$al in the early stages o" CD& and thecondition is disco!ered i" urinalysis shos that the idney is alloing theloss o" protein or red blood cells into the urine. o "ully in!estigate theunderlying cause o" idney da$age& !arious "or$s o" $edical i$aging&blood tests and o"ten renal biopsy are e$ployed to +nd out i" there is are!ersible cause "or the idney $al"unction.

     he +!e stages o" CD are based on the glo$erular +ltration rate (34R)herein the nor$al 34R is /1, $9$in/.;5$1. Stage / is hen there isidney da$age ith nor$al or 34R

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    5/63

    INTRODUCTION  Benign nephrosclerosis is a gradual and prolonged deterioration o" the

    renal arteries. 4irst the inner layer o" the alls o" s$aller !esselsthicens& and gradually this thicening spreads to the hole all&so$eti$es closing the central channel o" the !essel. 4at then beco$esdeposited in the degenerated all tissue. he larger arteries gain ane8cess o" elastic tissue& hich $ay bloc their channels. Both o" theseconditions cause the blood supply to the !ital idney areas to be

    bloced& and tissue deterioration ensues.

      n $alignant nephrosclerosis a si$ilar process occurs but at a $uch"aster rate. he disease $ay de!elop so rapidly that there is little ti$e"or gross idney changes to occur. he sur"ace o" the idney& hoe!er& isnearly alays co!ered ith large red blotches at points here bleeding

    has occurred. n the $alignant disease the arteriole alls thicen and$ay be closed o by rapid cell groth. he nuclei o" these cells die& andthe elastic +bers disappear. ith the loss o" the elastic +bres& the allso" the !essels beco$e $uch $ore "ragile and easily distended. Se!ereruptures and he$orrhages are "reuent. he arterioles o"ten suerspas$s that can "orce blood through lesions in the !essel alls thetissues beco$e sollen as a result.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    6/63

    INTRODUCTION

    Fccording to the 10// 6S Renal DataSyste$ (6SRDS) data& in the year 100

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    7/63

    INTRODUCTION

    chose this case because ant to gainco$prehensi!e noledge about the disease.

    HbIecti!es o" $y case study are the "olloing:   o understand the nature and pathophysiology o"

    the disease.   o identi"y signs and sy$pto$s e8hibited by the

    patient ith ESRD.   o assess the patient& +nd out need o" patient and

    co$e up ith appropriate inter!entions utili'ingthe nursing process.

       o pro!ide discharge plan to the patient ithESRD.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    8/63

    DEMOGRA!IC RO"I#E

      Aa$e: Patient 2.  Fge: ?5 years old  Se8: 2ale  Ci!il Status: 2arried  Religion: Se!enth day Fd!entist  Fddress: P-? Cantugas& 2ainit& SDA

      Date o" Birth: 0?0=/

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    9/63

    A$T MEDICA# !I$TOR%  he patient as diagnosed ith 7ypertension as early as 5/

    years o" age but did not co$ply ith his treat$ent regi$en. 7eould usually buy Captopril hene!er he "eels lie his bloodpressure is ele!ated.

    7e as ad$itted at Surigao 2edical Center on Dece$ber 10/5due to !o$iting and diarrhea. he patient#s doctor suggestedhi$ to undergo 7e$odialysis "or the reason that his seru$

    creatinine as ele!ated a$ounting to 51$gdl. 7oe!er& thepatient re"used& thining that he$odialysis as Iust a aste o"$oney and that sooner or later he ill die. Hn Fpril 10/?& he asbrought to CR7 by his daughter because he had an alteredsensoriu$& !o$iting& and peripheral ede$a. Fccording to hi$&

    his creatinine increased to //1 and his B6A as !ery ele!ated&he cannot recall the rest o" the history. 7e as then diagnosedith ESRD secondary to 7ypertensi!e Aephrosclerosis.Frterio!enous 4istula as created at his le"t ar$ on Fpril 0=&10/? by Dr.Jcong. he patient also !erbali'ed that his doctore8plained to hi$ the result o" his sonography that both o" his

    idneys shrun.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    10/63

    $OCIA# !I$TOR% 

     he patient li!es in P-? Cantugas& 2at-& SDA. 7e has 5children& to o" the$ ha!e their on "a$ily& and theyoungest is currently li!ing ith hi$ and his i"e attheir residence. Be"ore he as diagnosed ith ESRD&

    he as li!ing only ith his youngest daughter ho isstudying in 7igh School because his i"e oredabroad. F"ter his hospitali'ation& his i"e ent ho$eto tae care o" hi$. 7e "or$erly ored as a treasurerin their $unicipality and stopped hen he as alreadydiagnosed ith ESRD because he easily gets tired andhas to go on he$odialysis tice a ee. he patientdoes not s$oe& and only drins liuors occasionally.7e has a good relationship ith his neighbors.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    11/63

    "AMI#% !I$TOR% O" I##NE$$

       he patient !erbali'ed that his parentsha!e a history o" 7PA.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    12/63

    !%$ICA# A$$E$$MENT

    &ITA# $IGN$'  BP: /=0/00 $$7g K />0//0 $$7g   E2PERF6RE: 5=.?oC  P69SE RFE: >= bp$  RESPRFHRJ RFE: 1/ bp$

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    13/63

    $(IN'  Color: Dar bron  ntegrity: ntact  2oisture: Dry %ay sin  (L)pruritus M ar$s and bac

    !AIR'

      Color: Blac   hicness: hic and dry hair

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    14/63

    NAI#$'  Shape: Aor$al sy$$etrical   e8ture: S$ooth  Aailbed color: Pale

      Capillary Re+ll: Aor$al  Fppearance: Dirty

    "ACE'  Sy$$etry o" 2o!e$ents: Sy$$etrical  Fppearance: puy chees

    E%E$'  Color: hite  7olloness: Sunen  Pale conIuncti!a

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    15/63

    UI#$'  Color: Bron  Shape: Circular 

    Sy$$etry: Sy$$etricalAURIC#E$'  Aor$al and sy$$etrical   e8ture& elasticity& tenderness: 4ir$ non-tender

      Sin lesions: Ao sin lesions

    NO$E'  Sy$$etrical (-)%aring

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    16/63

    MOUT!'  (-)halitosis ithout dentures   eeth color: light yello  Fppearance: pale

    #UNG$'  Breath sounds: (L)cracles on both lung +elds

    A)DOMEN'  Distended

    ARM$'  Sy$$etrical& ith FN4 M 9 ar$

    #EG$'  Sy$$etrical& ith scar M posterior 9 cal"& ede$a (/L)

    on both "eet

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    17/63

    GORDON*$ T%O#OG% O" !EA#T! ATTERN

    !EA#T! ERCETION + !EA#T! MANAGEMENT   he patient rarely sees $edical attention hene!er he has

    an illness because he belie!es that it is Iust a aste o"$oney. Be"ore he as diagnosed ith ESRD& he does nottae any !ita$ins and only buys Captopril hene!er he"eels di''y and his BP beco$es ele!ated. But no he isalready co$pliant to his prescribed $edications ith thehelp o" his i"e by re$inding hi$ to tae his $eds. 7eundergoes he$odialysis tice a ee& and undergoes bloodtrans"usion o" PRBC hene!er his RBC count beco$es !ery

    lo usually e!ery 5 $onths. he i"e !erbali'ed that thepatient is !ery hard headed because the patient o"ten ti$eson#t listen to hi$ and his diet is still salty and high in "at.

     he patient $aintains a eight o" ,?.,g pre-7D andeight goal post-7D is ,/g.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    18/63

    NUTRITIONA# + META)O#IC ATTERN  7is usual ater intae is ?-= ti$es a day. 7is diet is usually

    salty and high in "at. 7e o"ten drins soda and Cobra energydrin "or 1-5 ti$es a day be"ore he as diagnosed. 7edrins liuors occasionally and ne!er s$oe. he patientdoes not ha!e "ood allergies. 7e o"ten has no appetite andhis i"e usually has to bring hi$ to restaurants to eat he!erbali'ed that his appetite depends on the s$ell andappearance o" the "ood. 7oe!er& he still eats salty "oodse!en though he#s already diagnosed ith ESRD. 7e does

    not li$it his %uid intae though his doctor ad!ised hi$ toli$it %uid intae to /9 per day. he patient also !erbali'edthat a"ter eating salty "oods or drining soda& he ille8perience selling o" the "eet and bone pains Iust hourslater.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    19/63

    E#IMINATION ATTERN   he patient usually !oids ,-; ti$es a day in

    scanty-$ini$al a$ount& dar yello in color orcolorless. 7is boel $o!e$ent is usually oncee!ery 1 days.

    ACTI&IT%, #EI$URE, AND RECREATIONA#ACTI&ITIE$  7e pre!iously ored as a treasurer in their

    2unicipal oOce. he patient did not engage ine8ercises be"ore and until no. 7e atchestele!ision $ore o"ten and does not usually go out"or a al. he patient does not do householdchores because he gets easily tired.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    20/63

    $#EE AND RE$T ATTERN   he patient usually sleeps at /0p$ and oe up at

    ?a$. H"ten ti$es he e8perienced aing up atnight to !oid. 7e !erbali'ed aron nga naingani

    nao& naa rao pir$i sa balay aon atulog ay dili$an o pa trabahuon saong asaa.

     

    COGNITI&E-ERCETUA# ATTERN   he patient is a college graduate. 7e has diOculty

    seeing near obIects. 7e e!en holds his cellphoneaay hile reading a te8t $essage. 7e is !erysensiti!e in the s$ell and appearance o" "ood hichaects his appetite.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    21/63

    $E#" ERCETION-$E#" CONCET ATTERN   he patient lies to sociali'e ith his or$ates be"ore.

    7e thought that he as healthy and does not ha!e anyproble$ about his hypertension. 7e !erbali'ed in an

    inappropriate aect ala gyud o nag tuo nga $uabutsa ingani& nga $aingani o& aron nghulat nalang o nus-a $a$atay.

     

    RO#E RE#ATION$!I

      7is pri$ary dialect is Surigaonon. 7e is $arried& ith 5children ho he is ell-supported and lo!ed. he patientis currently li!ing ith his i"e and youngest child. 7iseldest daughter ho is a nurse abroad is the only oneho supports hi$ on his treat$ents.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    22/63

    $E.UA#IT%-RERODUCTI&E ATTERN  6na!ailable.

     

    COING AND $TRE$$ TO#ERANCE  hene!er he has proble$s& he does not usually tell it to his "a$ily

    especially no because he does not ant to be a burden in the"a$ily.

     

    &A#UE$-)E#IE" ATTERN   he patient#s religion is Se!enth Day Fd!entist. 7e does not

    regularly go to Church but he alays pray to 3od. 7e reali'ed that

    pro$oting good health is really i$portant than to regret later inyour li"e particularly in his condition in hich he has to undergohe$odialysis "or a li"eti$e. 7oe!er& e!en though he is already onhe$odialysis& he does not change his li"estyle and diet because hebelie!es that it is oay to eat salty "oods and drin soda since he#salready on he$odialysis hich "unctions no as his idneys& and

    besides& he ill still die in the end.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    23/63

    RENE H4 FAFH2J FADP7JSH9H3J#ocation

     he idneys are a pair o" organs"ound along the posterior $uscularall o" the abdo$inal ca!ity. hele"t idney is located slightly $oresuperior than the right idney dueto the larger si'e o" the li!er on the

    right side o" the body. 6nlie theother abdo$inal organs& theidneys lie behind the peritoneu$that lines the abdo$inal ca!ity andare thus considered to beretroperitoneal organs. he ribs

    and $uscles o" the bac protectthe idneys "ro$ e8ternal da$age.Fdipose tissue non as perirenal"at surrounds the idneys and actsas protecti!e padding.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    24/63

    $tr/ct/re he idneys are bean-shaped ith thecon!e8 side o" each organ locatedlaterally and the conca!e side $edial.

     he indentation on the conca!e side o"

    the idney& non as the renal hilus&pro!ides a space "or the renal artery&

    renal !ein& and ureter to enter theidney.

    F thin layer o" +brous connecti!e tissue

    "or$s the renal capsule surroundingeach idney. he renal capsule pro!ides

    a sti outer shell to $aintain the shapeo" the so"t inner tissues.

    Deep to the renal capsule is theso"t&dense& !ascular renal corte0.Se!en cone-shaped renal pyra$ids "or$the renal $edulla deep to the renalcorte8. he renal pyra1ids are alignedith their bases "acing outard toard

    the renal corte8 and their ape8es pointinard toard the center o" the idney.

    Each ape8 connects to a $inor caly8& as$all hollo tube that collects urine. he$inor calyces $erge to "or$ 5 larger

    $aIor calyces& hich "urther $erge to"or$ the hollo renal pel!is at the

    center o" the idney. he renal pel!ise8its the idney at the renal hilus& here

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    25/63

    The Nephron

    Each idney containsaround / $illion

    indi!idual nephrons&the idneys#$icroscopic "unctionalunits that +lter bloodto produce urine. he

    nephron is $ade o" 1$ain parts: the renalcorpuscle and therenal tubule.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    26/63

      Responsible "or +ltering the blood& our renal corpuscle is"or$ed by the capillaries o" the glo$erulus and theglo$erular capsule (also non as Bo$an#s capsule). he glo$erulus is a bundled netor o" capillaries thatincreases the sur"ace area o" blood in contact the blood!essel alls. Surrounding the glo$erulus is the glo$erularcapsule& a cup-shaped double layer o" si$ple sua$ousepitheliu$ ith a hollo space beteen the layers.Special epithelial cells non as podocytes "or$ the layer

    o" the glo$erular capsule surrounding the capillaries o"the glo$erulus. Podocytes or ith the endotheliu$ o"the capillaries to "or$ a thin +lter to separate urine "ro$blood passing through the glo$erulus. he outer layer o"the glo$erular capsule holds the urine separated "ro$ the

    blood ithin the capsule. Ft the "ar end o" the glo$erularcapsule& opposite the glo$erulus& is the $outh o" therenal tubule.

      F series o" tubes called the renal tubule concentrate urineand reco!er non-aste solutes "ro$ the urine. he renal

    tubule carries urine "ro$ the glo$erular capsule to therenal el!is.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    27/63

     he cur!y +rst section o" the renaltubule is non as the pro8i$alcon!oluted tubule. he tubule cellsthat line the pro8i$al con!olutedtubule reabsorb $uch o" the ater andnutrients initially +ltered into the urine.

    6rine ne8t passes through the loop o"7enle& a long straight tubule thatcarries urine into the renal $edullabe"ore $aing a hairpin turn and

    returning to the renal corte8.4olloing the loop o" 7enle is the distalcon!oluted tubule.

    4inally& urine "ro$ the distalcon!oluted tubules o" se!eralnephrons enters the collecting duct&hich carries the concentrated urine

    through the renal $edulla and into therenal pel!is.

    4ro$ the renal pel!is urine "ro$ $anycollecting ducts co$bines and %osout o" the idneys and into the ureters.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    28/63

     he $ain "unction o" the idneys is to +lter

    ater& i$purities and astes "ro$ the blood. he blood "ro$ the body enters the idneysthrough the renal arteries. Hnce in the idney&the blood passes through the nephrons& here

    aste products and e8tra ater are re$o!ed. he clean blood is returned to the body throughthe renal !eins. he aste products +ltered"ro$ the blood are then concentrated into urine.

     he urine is collected in the renal pel!is. heureters $o!e the urine to the bladder& here itis stored. 6rine is passed out o" the bladder andthe body through the urethra.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    29/63

      ater !o1eostasis

     he idneys are able to control the !olu$e o" 3ater in the4ody by changing the reabsorption o" ater by the tubules o"the nephron. 6nder nor$al conditions& the tubule cells o" thenephron tubules reabsorb (!ia os$osis) nearly all o" the aterthat is +ltered into urine by the glo$erulus.

    ater reabsorption leads to !ery concentrated urine and theconser!ation o" ater in the body. he hor$ones antidiuretichor$one (FD7) and aldosterone both increase thereabsorption o" ater until al$ost /00G o" the ater +lteredby the nephron is returned to the blood. FD7 sti$ulates the

    "or$ation o" ater channel proteins in the collecting ducts o"the nephrons that per$it ater to pass "ro$ urine into thetubule cells and on to the blood. Fldosterone "unctions byincreasing the reabsorption o" AaL and Cl- ions& causing $oreater to $o!e into the blood !ia os$osis.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    30/63

      Acid5)ase !o1eostasis

     he idneys regulate the p7 le!el o" the blood by controlling thee8cretion o" hydrogen ions (7L) and bicarbonate ions (7CH5-).7ydrogen ions accu$ulate hen proteins are $etaboli'ed in theli!er and hen carbon dio8ide in the blood reacts ith ater to "or$carbonic acid (71CH5). Carbonic acid is a ea acid that partially

    dissociates in ater to "or$ hydrogen ions and bicarbonate ions.Both ions are +ltered out o" the blood in the glo$erulus o" theidney& but the tubule cells lining the nephron selecti!ely reabsorbbicarbonate ions hile lea!ing hydrogen ions as a aste product inurine. he tubule cells $ay also acti!ely secrete additional hydrogenions into the urine hen the blood beco$es e8tre$ely acidic.

       he reabsorbed bicarbonate ions enter the bloodstrea$ herethey can neutrali'e hydrogen ions by "or$ing ne $olecules o"carbonic acid. Carbonic acid passing through the capillaries o"the lungs dissociates into carbon dio8ide and ater& alloing us toe8hale the carbon dio8ide.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    31/63

      )lood ress/re !o1eostasis

     he idneys help to control blood pressure in the body by regulating the e8cretiono" sodiu$ ions and ater and by producing the en'y$e renin. Because blood is$ostly $ade o" ater& an increased !olu$e o" ater in the body results in an

    increase in the !olu$e o" blood in the blood !essels. ncreased blood !olu$e$eans that the heart has to pu$p harder than usual to push blood into !esselsthat are croded ith e8cess blood. hus& increased blood !olu$e leads toincreased blood pressure. Hn the other hand& hen the body is dehydrated& the!olu$e o" blood and blood pressure decrease.

     he idneys are able to control blood pressure by either reabsorbing ater to$aintain blood pressure or by alloing $ore ater than usual to be e8creted intourine and thus reduce blood !olu$e and pressure. Sodiu$ ions in the body help to$anage the body#s os$otic pressure by draing ater toards areas o" highsodiu$ concentration. o loer blood pressure& the idneys can e8crete e8trasodiu$ ions that dra ater out o" the body ith the$. Con!ersely& the idneys$ay reabsorb additional sodiu$ ions to help retain ater in the body.

    4inally& the idneys produce the en'y$e renin to pre!ent the body#s bloodpressure "ro$ beco$ing too lo. he idneys rely on a certain a$ount o" bloodpressure to "orce blood plas$a through the capillaries in the glo$erulus. " bloodpressure beco$es too lo& cells o" the idneys release renin into the blood. Reninstarts a co$ple8 process that results in the release o" the hor$one aldosterone bythe adrenal glands. Fldosterone sti$ulates the cells o" the idney to increase theirreabsorption o" sodiu$ and ater to $aintain blood !olu$e and pressure.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    32/63

      !or1ones

     he idneys $aintain a s$all but i$portant endocrine "unction byproducing the hor$ones calcitriol and erythropoietin.

      Calcitriol  is the acti!e "or$ o" !ita$in D in the body. ubulecells o" the pro8i$al con!oluted tubule produce calcitriol "ro$inacti!e !ita$in D $olecules. Ft that point& calcitriol tra!els

    "ro$ the idneys through the bloodstrea$ to the intestines&here it increases the absorption o" calciu$ "ro$ "ood in theintestinal lu$en.

      Erythropoietin (EPO) is a hor$one produced by cells o" theperitubular capillaries in response to hypo8ia (a lo le!el o"

    o8ygen in the blood). EPH sti$ulates the cells o" red bone$arro to increase their output o" red blood cells. H8ygenle!els in the blood increase as $ore red blood cells $ature andenter the bloodstrea$. Hnce o8ygen le!els return to nor$al&the cells o" the peritubular capillaries stop producing EPH.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    33/63

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    34/63

    AT!O!%$IO#OG% 

    http://var/www/apps/conversion/tmp/scratch_4/PATHOPHYSIOLOGY.docxhttp://var/www/apps/conversion/tmp/scratch_4/PATHOPHYSIOLOGY.docx

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    35/63

    #A)ORATOR% RE$U#T$

    COMONENT RE$U#T$NORMA#

    &A#UE$ 

    ANA#%$I$ 

    R)C 1.; ?.,-,.1 8 /0.? /5.,-/;.,gd9 Decreased

    !e1atocrit 1,.;G ?0-,1G Decreased

    )C

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    36/63

    COMONENT RE$U#T$ NORMA#

    &A#UE$

    ANA#%$I$

    )UN ,; ;-/>$gd9 ndicates renal proble$

    Creatinine 51 0.;-/.5$gd9 ndicates renal proble$

     he B6A and Creatinine ere belo their nor$al range thusshoing inability o" the idney to e8crete nitrogenous aste.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    37/63

    COMONENT RE$U#T$ NORMA# &A#UE$

     

    ANA#%$I$

     

    R)C 1.? ?.,-,.1 8 /00$l.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    38/63

    COMONENT RE$U#T$ NORMA# &A#UE$ ANA#%$I$ 

    Creatinine /5 0.;-/.5$gd9 ndicates renal

    proble$

     he Creatinine as belo nor$al range thus shoing inability o" theidney to e8crete nitrogenous aste.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    39/63

    COUR$E IN T!E ARD

     he patient arri!ed in the dialysis unit at around ;a$. he patient as ell-groo$ed. 7e had a pre-7D eighto" ,?.,g. 7e as cal$& cooperati!e& and hadspontaneous speech throughout the inter!ie.7oe!er& hen discussing sel" perception-sel" concept

    pattern& the patient displayed beha!ior suggesti!e o"altered sel"-concept such as a!oidance o" eye contactduring such discussion& and speaing in aninappropriate aect. 7is !ital signs throughout the

    dialysis period ere as "ollos: BP: /=0-/>0/00-//0$$7g& PR: >,-

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    40/63

    DRUG $TUD% DRUG

    NAME

    MoA INDICATION CONTRAINDICATION $IDEE""ECT$

    INTER&ENTION$

    Clonidine

    -Antihypertens

    ive

     

    Clonidine

    sti$ulatesalpha-

    1receptors in

    brainste$

    hich results

    in reduced

    sy$pathetic

    out%o "ro$

    the CAS and

    a decreasein peripheral

    resistance

    leading to

    reduced BP

    and pulse

    rate. t does

    not alter

    nor$alhe$odyna$i

    c response

    to e8ercise

    at

    reco$$ende

    d dosages.

    7ypertensio

    n& usedalone or as

    part o"

    co$bination

    therapy.

     

    7ypersensiti!ity.

    Disorders o" cardiacpace$aer acti!ity

    and conduction.

    Pregnancy and

    lactation.

    dry $outh&

    drosiness&di''iness&

    irritability&

    $ood

    changes& sleep

    proble$s

    (inso$nia or

    night$ares)&

    headache& earpain& "e!er&

    "eeling hot&

    constipation&

    diarrhea&

    sto$ach pain&

    increased

    thirst&

    decreaselibido&

    i$potence&

    cold sy$pto$s

    such as runny

    or stuy nose&

    snee'ing&

    cough& or sore

    throat

    FRAA3:

    Do not discontinueabruptly discontinue

    therapy by reducing the

    dosage gradually o!er

    1K? days to a!oid

    rebound hypertension&

    tachycardia& %ushing&

    nausea& !o$iting&

    cardiac arrhyth$ias

    (hypertensi!eencephalopathy and

    death ha!e occurred

    a"ter abrupt cessation

    o" clonidine).

    Do not discontinue

    transder$al therapy

    prior to surgery$onitor BP care"ully

    during surgery ha!e

    other BP-controlling

    drugs readily a!ailable.

    Continue oral clonidine

    therapy ithin ?hr. o"

    surgery then resu$e as

    soon as possibletherea"ter.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    41/63

    DRUGNAME

    Mechanis1o6 Action

    INDICATION CONTRAINDICATION

    $IDEE""ECT$

    INTER&ENTION$

    F$lodipine

    -Calciu$Channelblocer

    F$lodipinedecreasesarterial s$ooth

    $usclecontractilityandsubseuent!asoconstriction by inhibitingthe in%u8 o"calciu$ ionsthrough

    calciu$channels.nhibition o"

    the initial in%u8o" calciu$decreases thecontractileacti!ity o"arterial s$ooth

    $uscle cellsand results in!asodilation.

     he!asodilatoryeects o"a$lodipineresult in ano!erall

    decrease inblood pressure.

     reat$ent "orhypertension orin co$bination

    ith otherantihypertensi!es.

    7ypersensiti!ity to the drug. 

    Blood pressureless than

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    42/63

    DRUG

    NAME

    MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    T3ynsta 

     ynstacontains aco$binationo"F$lodipine

    and el$isartan.F$lodipineis a calciu$channelblocer.F$lodipinerela8es(idens)

    blood!essels andi$pro!esblood %o.

     el$isartanis anangiotensin receptor

    antagonist. el$isartaneeps blood!essels "ro$narroing&hich loersbloodpressure andi$pro!es

    blood %o.

     his product

    is used to

    treat

    hypertension.

     

     hese

    $edications

    are used

    together

    hen one

    drug is notcontrolling

    the blood

    pressure. he

    doctor $ay

    direct the

    patient to

    start taingthe indi!idual

    $edications

    +rst& and

    then sitch

    to this

    co$bination

    product i" it is

    the best dose

    7ypersensiti!ity to

    F$lodipine and

     el$isartan.

     

    Chec ith thephysician +rst i" thepatient has any o"the "olloing:Se!ere Aarroing o"the Fortic 7eartNal!e& Renal FrteryStenosis& Fbnor$ally9o Blood Pressure&9i!er Proble$s&Se!ere 9i!er Disease&idney Disease&Pregnancy&Decreased BloodNolu$e& E8tre$e

    9oss o" Body ater&7igh F$ount o"Potassiu$ in theBlood. 

    Signs o" an

    allergic

    reaction to

     ynsta: hi!es

    diOculty

    breathingselling o"

    your "ace&

    lips& tongue&

    or throat.

     

    Co$$on

     ynsta side

    eects $ayinclude:

    selling in the

    hands or "eet&

    "ast

    heartbeats&

    di''iness&

    drosiness&

    tired "eeling

    %ushing

    (ar$th&

    redness& or

    tingly "eeling)

    bac pain or

    nausea&

    diarrhea&

    sto$achpain. 

    Chec blood

    pressure be"ore

    and a"ter gi!ing

    the drug.

     

    nstruct patient to

    a!oid getting up

    too "ast "ro$ a

    sitting or lying

    position& or he

    $ay "eel di''y.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    43/63

    DRUG

    NAMEMoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    Terra6err

    on

     -&it7 and

    1inerals

    s/pple1e

    nt8

    Antiane1i

    c

     

    Consists o"

    4olic Fcid&

    ron (4errousSul"ate)&Nita

    $in

    B/&Nita$in

    B/1&Nita$in

    B1&Nita$in

    B5&

    Nita$in B=&

    Nita$in C.

     

    Sti$ulates

    the

    he$atopoieti

    c syste$.

    Pre!ention

    and

    treat$ento" iron

    de+ciency

    ane$ia. 

     hro$boe$bolis$&

    erythre$ia&

    erythrocytosis&increased sensiti!ity

    to cyanocobala$in.

    Aausea

    No$iting

     Fllergic

    reaction:

    6rticaria.

    Drin ith

    orange Iuice to

    i$pro!eabsorption and

    to $ini$i'e

    nausea.

     

    Do not tae ith

    $il& tea or

    coee.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    44/63

    DRUG

    NAME

    MoA INDICATION CONTRAINDICATION $IDEE""ECT$

    INTER&ENTION$

    Clopidogr

    el 

    -

    antiplatelet 

    nhibits

    platelet

    acti!ation

    andaggregati

    on

    through

    the

    irre!ersibl

    e binding

    o" its

    acti!e$etabolit

    e to FDP

    receptors

    on

    platelets.

    4or pre!ention

    or treat$ent

    o" stroe and

    heart attac.

    7ypersensiti!ity&

    Peptic ulcer or

    intracranial

    he$orrhage.

     

    6se cautiously ith

    bleeding disorders&

    recent surgery& renal

    or hepatic

    i$pair$ent&

    pregnancy. 

    Di''iness&

    easy

    bruising& 3

    upset&headache.

     

    Fd!erse

    eects:

    Rash& DHB&

    chest

    tightness&

    con"usion&tarry stool.

    2onitor blood

    pressure.

    Pro!ide co$"ort

    $easures andarrange "or

    analgesics i"

    headache occurs.

    Pro!ide s$all&

    "reuent $eals i" 3

    upset occurs.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    45/63

    DRUG NAME MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    Montel/9as

    t :

    #evocitiri;ine

     

    Binds to

    cysteinyl

    leuotrien

    e type /

    (Cys9 / )

    receptor

    in the

    upper and

    loer

    airays to

    pre!entleuotrien

    e-

    $ediated

    eects

    associated

    ith

    allergic

    rhinitis.

    Prophyla8is

    or

    treat$ento" allergic

    reactions

    such as

    chronic

    urticaria&

    obstructi!e

    airaydiseases

    and rhinitis.

    7ypersensiti!ity&

    patients ith

    hepatici$pair$ent.

    Aausea&

    dry $outh&

    drosiness

    &

    dyspepsia&

    headache.

    Fd!ise patients that

    $onteluast can be

    taen ithout

    regard to $eals but

    to tae it ith "ood

    i" sto$ach upset

    occurs.

    Fd!ise patients ith

    non aspirin

    sensiti!ity to

    continue a!oidanceo" aspirin and

    ASFDs hile taing

    the drug.

     

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    46/63

    DRUG

    NAMEMoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    Ni6edipin

    e

     -calci/1

    channel

    4loc9er

     

    Decreases

    arterial

    s$ooth$uscle

    contractility

    and

    subseuent

    !asoconstricti

    on by

    inhibiting the

    in%u8 o"calciu$ ions

    through

    calciu$

    channels.

    4or treat$ent

    o"

    hypertension.

    7ypersensiti!ity to the

    drug& CFD& history o"

    heart attac.

    Di''iness&

    urticaria&

    %ushing&tre$ors&

    nausea&

    heartburn.

    2onitor BP

    care"ully during

    titration period.Patient $ay

    beco$e se!erely

    hypotensi!e&

    especially i" also

    taing other drugs

    non to loer BP.

    ithhold drug and

    noti"y physician i"systolic BP @

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    47/63

    DRUG NAME MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    N-

    Acetylcystein

    -1/colytic 

    E8erts its

    $ucolytic

    action

    through

    its "ree

    sul"hydryl

    group&

    hich

    reduces

    the

    disul+de

    bonds in

    the

    $ucus

    $atri8

    and

    loers

    $ucus

    !iscosity.

    ndicated as

    adIu!ant

    therapy "or

    patients ith

    abnor$al&

    !iscous or

    thic

    secretions.

    Drug hypersensiti!ity Aausea&

    !o$iting&

    hypotension

    & diarrhea or

    constipation

    .

    2onitor patient#s NS

    especially RR and

    7R.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    48/63

    DRUG

    NAME

    MoA INDICATION CONTRAINDICATIO

    N

    $IDE E""ECT$ INTER&ENTION$

    CaCO< 

    -phosphat

    e 4inder

    -dietary

    s/pple1e

    nt

    Fs dietarysupple$ent&used to

    pre!ent ortreatnegati!ecalciu$balance inosteoporosis& it helps topre!ent ordecrease

    the rate o"bone loss.

    Phosphatebinder:Binds ithdietaryphosphateto "or$

    insolublecalciu$phosphate&hich ise8creted in"eces.

    6sed "or the

    treat$ent o"

    hyperphosphate$

    ia& nor$ali'ing

    phosphate

    concentrations in

    patients ith CD.

    t can also be

    used as a calciu$

    supple$ent in

    these patients.

    7ypersensiti!ity&

    patients ith

    hypercalce$ia&

    and

    hypophate$ia.

    Aausea&

    %atulence&

    constipation&

    8erosto$ia&

    !o$iting.

    2onitor seru$

    calciu$ and

    phosphate le!els.

     

    Should be gi!en

    ith $eals to

    increase

    absorption. 2ay

    decrease iron

    absorption& so

    should bead$inistered /-1

    hours be"ore or

    a"ter iron

    supple$entation

    li$it intae o"

    ith bran& "oods

    high in o8alates

    or hole graincereals hich

    $ay decrease

    calciu$

    absorption.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    49/63

    DRUG

    NAME

    MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    "e$O=

    -iron

    s/pple1ent

    Ele!ates

    seru$ iron

    concentratio

    n hich thenhelps to "or$

    7igh or

    trapped in

    the reticulo-

    endothelial

    cells "or

    storage and

    e!entualcon!ersion to

    a usable

    "or$ o" iron.

    6sed to treat

    iron de+ciency

    ane$ia.

    7ypersensiti!ity&

    se!ere hypotension.

    Aausea&

    !o$iting&

    di''iness.

    Fd!ise patient to

    tae $edicine as

    prescribed.

    Caution patient to$ae position

    changes sloly to

    $ini$i'e orthostatic

    hypotension.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    50/63

    DRUG NAME MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    $odi/1

    )icar4onate 

    Sodiu$

    Bicarbo

    nate

    acts asan

    alalini

    'ing

    agent

    by

    releasin

    g

    bicarbonate

    ions.

    6sed "or the

    treat$ent o"

    $etabolic

    acidosishich $ay

    occur in

    se!ere renal

    disease

    2etabolic or respi.

    alalosis&

    hypocalce$ia&

    hypo!entilation& andhypersensiti!ity to

    drug.

    7eadache&

    anore8ia&

    unpleasant

    taste& tired"eeling&

    nausea&

    andor

    !o$iting.

    2onitor urinary p7

    and urine output as

    guide "or dosing.

     2onitor patients NS

    especially RR and

    7R.

     

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    51/63

    DRUG NAME MoA INDICATION CONTRAINDICATION $IDE

    E""ECT$

    INTER&ENTION$

    !ydro0i;ine 

    -antihista1ine 

    7ydro8y'ine

    reduces

    acti!ity inthe central

    ner!ous

    syste$. t

    also acts as

    an

    antihista$in

    e that

    reduces thenatural

    che$ical

    hista$ine in

    the body.

    Co$$only

    used to treat

    pruritus inpatients ith

    ESRD.

    7ypersensiti!ity&

    glauco$a&

    Dry $outh&

    drosiness&

    nausea&hypotensio

    n.

    Fssess patient#s

    alertness.

    nstruct patient notto drin alcohol.

    nstruct patient to

    increase %uid

    intae.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    52/63

    A$$E$$MENT DIAGNO$I$ #ANNING INTER&ENTION$

    O4>ective data'

    Crea'

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    53/63

     

    $/4>ective data'

    HUsahay ra9o

    1a9aihi nya

    ginag1ay ra

    /sahay 1/ t/lo ra

    gy/d7 ag 1/9aon

    9o /g parat1angh/pong

    dayon a9ong tiil7

    O4>ective data'

    resence o6

    peripheral

    ede1a grade

    B Distended

    a4do1en

    /y 6ace

    Olig/ria

    :crac9les in

    the l/ngs

    Crea'

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    54/63

    A$$E$$MENT DIAGNO$I$ #ANNING INTER&ENTION$

    O4>ective data'

    peripheral

    ede1a

    grade B

    Distendeda4do1en

    /y 6ace

    "reJ/ent

    scratching o6

    the ar1s7

     

    I1paired s9in

    integrity rt

    ede$a and

    pruritus FEBperipheral

    ede$a&

    distended

    abdo$en&

    "reuent

    scratching on the

    ar$s& puy "ace.

     

    Short er$: F"ter ?

    hours o" nurse-patient

    interaction& the patient

    ill establish beha!iorsto pre!ent sin

    da$age.

     

    9ong er$: he patient

    ill $aintain intact

    sin.

     

    - nspect patient#s sin "or changes in

    color& turgor& !ascularity.

    - Fssess patient#s peripheral ede$a&ele!ate legs to pro$otes !enous

    return& li$iting ede$a "or$ation.

    - Pro!ide soothing sin care to

    patient& applying oint$ent or crea$

    to relie!e dry and craced sin.

    - eep bedchair linen dry andrinle-"ree to reduce sin irritation.

    - Reco$$end patient to use cool&

    $oist co$presses to apply pressure

    rather than scratch pruritic areas to

    pre!ent sin inIury.

    - nstruct patient to eep +ngernailsshort.

     

    A$$E$$MENT DIAGNO$I$ #ANNING INTER&ENTION$

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    55/63

     

    $/4>ective data'

    HM/9aon gihapon

    9og 1ga parat

    9ay nag dialysis

    na 4ita3 9o para

    1a p/slan /nya

    1ao ra gihapon

    1a1atay ra1an

    gihapon7 as

    ver4ali;ed 4y the

    patient7 

    DeKcient

    9no3ledge rt

    in"or$ation

    $isinterpretatio

    n about dialysis

    therapy.

     

    Short er$

     

    ithin ? hours o" nursing

    inter!entions& the

    patient ill !erbali'e

    understanding o"

    condition and potential

    co$plications.

     

    9ong er$

     

     he patient ill initiate

    necessary li"estylechanges.

     

    - Re!ie disease process and prognosis

    and "uture e8pectations. his pro!ides

    noledge base "ro$ hich patient

    can $ae in"or$ed choices.- Re!ie patient#s diet and %uid

    restriction as prescribed and e8plain to

    the patient the ad!antage o" eating

    the ordered diet.

    - Educate patient that he$odialysis

    treat$ent does not $ean he can eathate!er he lies. he pt. does not

    recei!e dialysis treat$ent daily so he

    needs to be care"ul o" hat he eats to

    pre!ent co$plication such as li"e-

    threatening ure$ia.

    - n"or$ patient that eating therestricted diet can "urther increase the

    patient#s blood pressure& and can also

    precipitate bone pains and ede$a.

     

    DIAGNO$I$ #ANNING INTER&ENTION$

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    56/63

    DIAGNO$I$ #ANNING INTER&ENTION$Ris9 6or In>/ry

    r5t in6ection7

     

    ithin ? hours o" nursing

    inter!entions& the patient ill

    ha!e patent !ascular access

    and be "ree o" in"ection.

     

    - 2onitor internal FN shunt patency at "reuent

    inter!als. Palpate sin around shunt "or ar$th.

    Di$inished blood %o results in coolness o"

    shunt.

    - Palpate "or distal thrill. hrill is caused by

    turbulence o" high-pressure arterial blood %o

    entering lo-pressure !enous syste$ and should

    be palpable abo!e !enous e8it site.

    - Aote color o" blood andor ob!ious separation o"

    cells and seru$. Change o" color "ro$ uni"or$

    $ediu$ red to dar purplish red suggests

    sluggish blood %o andor early clotting.

    Separation in tubing is indicati!e o" clotting. Nery

    dar reddish-blac blood ne8t to clear yello %uid

    indicates "ull clot "or$ation.

    - F!oid trau$a to shunt by handling tubing gently&

    $aintaining cannula align$ent. Aot taing BP or

    draing blood sa$ples in shunt e8tre$ity. o

    decrease ris o" clotting or disconnection.

    - nstruct patient not to sleep on side ith shunt or

    carry pacages& boos& purse on aected

    e8tre$ity.

    Fd$inister lo-dose o" 7eparin i" indicated to

    A$$E$$MENT DIAGNO$I$ #ANNING INTER&ENTION$  Ris "or    

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    57/63

    O4>ective' L6atig/eLpale 1/co/s1e14ranesLpallor general

    appearance R)C' 27=!g4' 7!ct' 2

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    58/63

    DI$C!ARGE #AN

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    59/63

    DI$C!ARGE #AN

     

    nstruct patient to strictly tae $edicines as directedand to $ae a list o" the $edicines& !ita$ins& andherbs that the patient is taing& including the a$ounts&hen and hy the patient tae the$. nstruct also thepatient to bring the list to "ollo-up !isits. 2edicine list

    should be carry by the patient in case o" an e$ergency.  nstruct patient to eigh sel" daily& "olloing the goal

    eight ordered by his physician.  n!ol!e and assist patient in $aing his e8ercise plan

    as directed. Regular e8ercise can help the patient

    $anage high blood pressure.  Strongly ad!ise patient to uit s$oing and a!oid

    drining alcohol.  Fd!ice patient to a!oid stress related "actors and ha!e

    adeuate rest.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    60/63

       each the patient to properly care his FN4 or FN3 by"olloing these steps:

    Clean the sin o!er the +stula or gra"t e!ery day ith soap and

    ater.  ae the bandage o the +stula or gra"t ? to = hours a"ter dialysis.

    Chec the +stula or gra"t e!ery day "or good blood %o bytouching it ith +ngertips. he bu''ing sensation $eans that it isoring.

    Chec "or bleeding& pain& redness& or selling. hese $ay be signs

    o" in"ection or a clogged +stula or gra"t.  o pre!ent da$age to the +stula or gra"t& no one should tae

    blood pressure or dra blood "ro$ the ar$ ith the +stula orgra"t.

    Should not ear tight-+tting shirts& Ieelry (such as bracelets)that $ay restrict blood %o on the access ar$.

    $aing sure the straps or handles don#t tighten around the +stulahen carrying things (groceries& bags& luggage)&

    2aing sure that the patient#s body& pillo or cushion doesn#t reston the ar$ ith +stula hen sitting or sleeping&

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    61/63

      nstruct patient to as his doctor i" he need

    !accines. n"ections such as pneu$onia&in%uen'a& and hepatitis can be $ore har$"ulor $ore liely to occur hen a person ha!eCD. Naccines reduce the ris o" in"ection ith

    these !iruses.  nstruct patient to "ollo up chec-up regularly

    ith his physician as directed.  nstruct patient to eat "oods directed by his

    doctor. 7is doctor $ay ad!ise hi$ to eat "oodlo in sodiu$& potassiu$& phosphorus& orprotein. he patient $ay need to see adietitian i" he needs help planning $eals.

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    62/63

     

    nstruct patient to discuss ith hisphysician regarding ho $uch %uid hehas to drin e!ery day and hat %uidsthe patient can and cannot drin.

      Encourage patient to suc on hard candyor che gu$ to help eep $outh $oistithout ha!ing to drin liuids.

      nstruct patient to see $edical attentioni$$ediately i" the sin around the +stulaor gra"t is pain"ul& hot& red& or sollen.

    REA#IATION

  • 8/19/2019 End Stage Renal Disease 2o Hypertensive Nephrosclerosis

    63/63

    REA#IATION

      7igh blood pressure can aect the idneys and can

    cause renal da$age.  End-Stage Renal Disease brings $any co$plications

    to the body that causes the patient to suer.  Renal disease is a progressi!e disease and is

    asy$pto$atic at +rst renal "ailure can be pre!entedthru regular chec-up and early inter!ention.

      7a!ing an ESRD is costly& hassle& and boring youha!e to spend $oney and ?-,hr. o" your ti$e perdialysis session "or the rest o" your li"e. Jou ha!e to

    $ae changes such as $odi"ying your li"estyle anddiet to a!oid co$plications.

       Jou ill ha!e an altered body i$age.